King's Health Economics
@khe_kings
Updates from King's Health Economics (KHE) research group at King's College London
@KingsHSPR @KingsIoPPN @KingscollegeLon
ID: 338387375
https://www.kcl.ac.uk/khe 19-07-2011 14:17:57
1,1K Tweet
2,2K Followers
956 Following
New report by The Centre for Health Economics Dr Adriana Castelli James Gaughan Arabadzhyan & Chalkley on NHS output, input & productivity growth is now available. Read at bit.ly/3Wb6MXv (1/5)
Need to map from PHQ-9/GAD-7 to EQ-5D-3L for economic evaluation (who doesn't?)? Clara's latest paper has you covered: rdcu.be/dF63D Matt Franklin NIHR Yorkshire & Humber ARC The Centre for Health Economics SCHARR
Good afternoon! π Itβs Dr Nina Higson-Sweeney, and I am live tweeting from King's College London, where attendees are starting to arrive for a very special event focused on the BESST Trial! "BESST? What do you mean by BESST?" Don't worry - I've got you covered π π§΅THREAD #BESSTtrial
BESST Trial Four characters feature throughout DISCOVER, acting as peer role models who experience anxiety, worry, and depression. Through videos delivered over the course of the workshop, students watch the characters learn new ways of thinking and managing their concerns #BESSTtrial
BESST Trial The session has now reached its conclusion - but what a host of brilliant talks! I don't think I'm the only one who is keen to continue following the progress of #BESSTtrial, and seeing if it can be implemented on a larger scale. Keep your eyes peeled for more events soon! π
BESST Trial And here is a photo of the #BESSTtrial team, with more on the slide in the background! What a brilliant achievement π€© James Shearer π³οΈβππ» Sarah Byford Jess Peter Fonagy Ben Carter
Today our CEO Dr Sarah Hughes spoke about all this and more at the Resolution Foundation event The Cost of Poor Health. If you missed the session, you can catch up here π 5/5 youtube.com/live/Yzu8H6_uPβ¦
New research out with colleagues from UK Health Security Agency finds: * 90% of BBV testing happens in inpatient settings meaning those who are never admitted are generally being missed. * Of those who were anti-HCV positive would have benefitted from treatment, only 58% received treatment.
Excited to share our latest paper on a nationwide survey addressing key issues in economic evaluations for HTA in China. Read it here: doi.org/10.1016/j.jval⦠#HealthEconomics #HTA #EconomicEvaluation #China #HealthcareResearch King's Health Economics HSPRD IOPPN